HLA and Risk of Diffuse Large B Cell Lymphoma After Solid Organ Transplantation

Transplantation - United States
doi 10.1097/tp.0000000000001025
Full Text
Abstract

Available in full text

Categories
Transplantation
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Diffuse Large B-Cell Lymphoma

2020English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Diffuse Large B-Cell Lymphoma of Bones in a Patient After Allogeneic Hematopoietic Stem Cells Transplantation Due to Hodgkin’s Lymphoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma With Residual Extranodal Involvement

Korean Journal of Internal Medicine
Internal Medicine
2008English

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma

Frontiers in Oncology
Cancer ResearchOncology
2020English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy